Menora Mivtachim Holdings LTD. Acquires 625,000 Shares of GE HealthCare Technologies Inc. $GEHC

Menora Mivtachim Holdings LTD. increased its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 57.3% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 1,715,250 shares of the company’s stock after purchasing an additional 625,000 shares during the period. Menora Mivtachim Holdings LTD.’s holdings in GE HealthCare Technologies were worth $128,815,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also bought and sold shares of the company. Godsey & Gibb Inc. bought a new position in GE HealthCare Technologies during the 3rd quarter worth $26,000. E Fund Management Hong Kong Co. Ltd. grew its position in shares of GE HealthCare Technologies by 130.7% in the 3rd quarter. E Fund Management Hong Kong Co. Ltd. now owns 346 shares of the company’s stock valued at $26,000 after buying an additional 196 shares during the last quarter. Allianz SE increased its stake in shares of GE HealthCare Technologies by 165.2% in the second quarter. Allianz SE now owns 350 shares of the company’s stock valued at $26,000 after buying an additional 218 shares during the period. Oakworth Capital Inc. increased its stake in shares of GE HealthCare Technologies by 1,876.2% in the third quarter. Oakworth Capital Inc. now owns 415 shares of the company’s stock valued at $31,000 after buying an additional 394 shares during the period. Finally, Piscataqua Savings Bank raised its position in shares of GE HealthCare Technologies by 173.4% during the third quarter. Piscataqua Savings Bank now owns 473 shares of the company’s stock worth $36,000 after acquiring an additional 300 shares during the last quarter. 82.06% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on the company. UBS Group lowered GE HealthCare Technologies from a “neutral” rating to a “sell” rating and lifted their price objective for the stock from $73.00 to $77.00 in a research note on Thursday, January 15th. Bank of America increased their target price on shares of GE HealthCare Technologies from $82.00 to $92.00 and gave the company a “neutral” rating in a research report on Monday, January 5th. BTIG Research boosted their price target on shares of GE HealthCare Technologies from $87.00 to $91.00 and gave the stock a “buy” rating in a research report on Wednesday, February 4th. Stifel Nicolaus increased their price objective on shares of GE HealthCare Technologies from $95.00 to $98.00 and gave the stock a “buy” rating in a research report on Wednesday, February 4th. Finally, The Goldman Sachs Group reissued a “buy” rating and set a $98.00 target price on shares of GE HealthCare Technologies in a research note on Friday, January 9th. Seven analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $92.17.

GE HealthCare Technologies Stock Performance

Shares of GEHC stock opened at $70.33 on Friday. The company has a market cap of $32.05 billion, a price-to-earnings ratio of 15.42, a price-to-earnings-growth ratio of 1.60 and a beta of 1.03. GE HealthCare Technologies Inc. has a 52 week low of $57.65 and a 52 week high of $89.77. The company has a quick ratio of 1.13, a current ratio of 1.37 and a debt-to-equity ratio of 0.91. The firm has a 50 day moving average of $81.02 and a 200-day moving average of $78.51.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings data on Wednesday, February 4th. The company reported $1.44 earnings per share for the quarter, beating the consensus estimate of $1.40 by $0.04. The company had revenue of $5.70 billion during the quarter, compared to analyst estimates of $5.60 billion. GE HealthCare Technologies had a net margin of 10.11% and a return on equity of 21.35%. GE HealthCare Technologies’s revenue for the quarter was up 7.1% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.45 EPS. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. On average, equities analysts forecast that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Friday, April 3rd will be paid a $0.035 dividend. This represents a $0.14 annualized dividend and a yield of 0.2%. The ex-dividend date of this dividend is Thursday, April 2nd. GE HealthCare Technologies’s payout ratio is 3.07%.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.